SLI
2.049,68
PKT
-15,41
PKT
-0,75
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.10.20 | Roche buy | Jefferies & Company Inc. | |
| 15.10.20 | Roche Outperform | Bernstein Research | |
| 15.10.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 15.10.20 | Roche overweight | JP Morgan Chase & Co. | |
| 15.10.20 | Zurich Insurance Sector Perform | RBC Capital Markets | |
| 15.10.20 | Swiss Re Outperform | RBC Capital Markets | |
| 14.10.20 | ABB (Asea Brown Boveri) buy | Kepler Cheuvreux | |
| 14.10.20 | Novartis buy | UBS AG | |
| 14.10.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 13.10.20 | Nestlé Outperform | Bernstein Research | |
| 13.10.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 13.10.20 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 12.10.20 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.10.20 | Swiss Re overweight | Barclays Capital | |
| 09.10.20 | UBS Neutral | JP Morgan Chase & Co. | |
| 09.10.20 | Givaudan Hold | Deutsche Bank AG | |
| 09.10.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 09.10.20 | Givaudan buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 09.10.20 | ams-OSRAM buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 09.10.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.10.20 | Roche Neutral | Credit Suisse Group | |
| 08.10.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 08.10.20 | Givaudan Underperform | Bernstein Research | |
| 08.10.20 | ams-OSRAM buy | Deutsche Bank AG | |
| 08.10.20 | Givaudan Equal-Weight | Morgan Stanley | |
| 08.10.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 08.10.20 | Givaudan add | Baader Bank | |
| 07.10.20 | Givaudan buy | UBS AG | |
| 06.10.20 | UBS Equal weight | Barclays Capital | |
| 06.10.20 | ams-OSRAM Outperform | Credit Suisse Group | |
| 05.10.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 05.10.20 | Holcim overweight | Morgan Stanley | |
| 05.10.20 | UBS Sector Perform | RBC Capital Markets | |
| 05.10.20 | UBS Sector Perform | RBC Capital Markets | |
| 01.10.20 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 01.10.20 | Roche buy | Jefferies & Company Inc. | |
| 01.10.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 30.09.20 | Roche buy | UBS AG | |
| 30.09.20 | Roche buy | Jefferies & Company Inc. | |
| 30.09.20 | Novartis Conviction Buy | Goldman Sachs Group Inc. |